Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,020 INR | -0.48% | +2.52% | +25.74% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NATCO PHARMA LIMITED | Other Pharmaceuticals | -0.48% | +2.52% | +25.74% | +64.99% | +99.96% | 2.2B |
Technical Rankings Surperformance
- Stock Market
- Equities
- NATCOPHARM Stock
- Charts NATCO Pharma Limited
- Comparison Chart